Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05863676 · ClinicalTrials.gov registry record
Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy
A clinical trial of Gender Dysphoria and Transgender, sponsored by University of Pittsburgh.
- Active
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT05863676 is a study of Gender Dysphoria and Transgender that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 20 participants, below the 176-participant average among 8 other Gender Dysphoria trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05863676, a study of Gender Dysphoria and Transgender, is active but no longer recruiting, sponsored by University of Pittsburgh.
- ACTIVE NOT RECRUITING
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to learn about fertility preservation in the gender-diverse community. The main objectives it aims to understand are to: 1. To optimize techniques for cryopreservation of ovarian tissues, including determining efficacy of cryopreservation techniques. 2. To investigate factors affecting ovarian tissue and follicles, such as previous treatment with leuprolide acetate, or hormone therapy
Conditions Studied
Interventions
- PROCEDURE Oophorectomy
- DIAGNOSTIC_TEST Infectious Disease Testing
Study Locations (1)
Pennsylvania
- Magee-Womens Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2020-07-14 |
| Est. Completion | 2030-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05863676
The ClinicalTrials.gov registry entry for NCT05863676 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 176-participant average among 8 other Gender Dysphoria trials with a reported enrollment target (89% lower). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gender Dysphoria appearing as the primary indexed condition, and to 2 interventions - of which Oophorectomy is the first listed.
NCT05863676 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05863676 about?
NCT05863676 is a clinical study titled "Ovarian Tissue Cryopreservation in the Setting of Gender-affirming Therapy". The goal of this study is to learn about fertility preservation in the gender-diverse community. The main objectives it aims to understand are to: 1. To optimize techniques for cryopreservation of ovarian tissues, including determining efficacy of cryopreservation techniques. 2. To investigate fact...
What is the current status of trial NCT05863676?
This trial is currently active not recruiting. The enrollment target is 20 participants. The study started on 2020-07-14. Estimated completion is 2030-07.
What conditions does trial NCT05863676 study?
This clinical trial studies the following conditions: Gender Dysphoria, Transgender.
What interventions are being tested in trial NCT05863676?
The interventions under investigation include: Oophorectomy (PROCEDURE), Infectious Disease Testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05863676?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05863676 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gender Dysphoria
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pubertal Blockade and Estradiol Effects on Cardiometabolic Health for Transitioning Youth
RECRUITING
-
Evaluating the Efficacy of Force Modulating Tissue Bridge Device in Preventing Hypertrophic Scars Following Gender-Affirming Mastectomy
RECRUITING · NA
-
Development of Effective, Opioid Sparing Techniques for Peri-operative Pain Management of Transgender Patients Undergoing Gender Affirming Surgeries
RECRUITING · Phase 3
-
Topical Estrogen: Brief Intervention to Improve Postoperative Experience for Transgender Men Undergoing Hysterectomy
RECRUITING · Phase 3
-
Effect of Nitropaste in Chest Masculinizing Surgery
RECRUITING · Phase 4
-
Testicular Tissue Cryopreservation in the Setting of Gender-Affirming Therapy
ACTIVE NOT RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.